Clinical trials
Phase 1 Sarcoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2022 | 3 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Yunying Medical Technology | 5 |
| Grupo Espanol de Investigacion en Sarcomas | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Base Therapeutics (Shanghai) Co., Ltd. | 1 |
| CBA Research | 1 |
| Celon Pharma SA | 1 |
| CytoMed Therapeutics Pte Ltd | 1 |
| Genzada Pharmaceuticals USA, Inc. | 1 |
| HRYZ Biotech Co. | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 22 |
| Stomach Neoplasms | 7 |
| Breast Neoplasms | 4 |
| Carcinoma | 3 |
| Colorectal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Osteosarcoma | 3 |
| Pancreatic Neoplasms | 3 |
| Bone Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.